<DOC>
	<DOCNO>NCT00363857</DOCNO>
	<brief_summary>A 14-Week clinical research study compare effectiveness safety ropinirole placebo ( inactive sugar pill ) treatment patient Restless Legs Syndrome ( RLS ) United States .</brief_summary>
	<brief_title>A Clinical Research Study Testing Ropinirole Treatment Restless Legs Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Ropinirole</mesh_term>
	<criteria>Inclusion criterion : Patients diagnose Restless Legs Syndrome ( RLS ) symptom : uncomfortable `` creepycrawly '' sensation legs , overwhelm urge move leg relieve sensation , sensation go away move legs , trouble fall asleep stay asleep symptom . Patients must give write informed consent prior specific study procedure . Exclusion criterion : Patients suffer narcolepsy , sleep terror disorder , sleepwalk disorder , breathe related sleep disorder . Patients diagnose renal failure ( endstage renal disease ) iron deficient anemia pregnancy . Patients suffer movement disorder ( i.e . Parkinson 's Disease ) . Patients medical condition diabetes , peripheral neuropathy , rheumatoid arthritis , fibromyalgia syndrome . Participation clinical drug device trial last three month . Other inclusion exclusion criterion evaluate physician .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>fatigue</keyword>
	<keyword>sleep</keyword>
	<keyword>sleep disorder</keyword>
	<keyword>Legs</keyword>
	<keyword>RLS</keyword>
	<keyword>Restless Legs Syndrome</keyword>
	<keyword>Ropinirole</keyword>
</DOC>